Gelteq (GELS) Stock Price, News & Analysis

Company Overview

Gelteq Inc. is a biotechnology company which specializes in the formulation, development and manufacturing of ingestible gel platform designed for nutrient and drug delivery. The Company is focused on advancing and commercializing its delivery solutions within core verticals pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications and sports nutrition. Gelteq Inc. is based in NEW YORK.

Key Stats

• Today's Range: $1.39 to $1.51
• 50-Day Range: $1.42 to $2.95
• 52-Week Range: $0.77 to $5.50
• Volume: 113,848 shs
• Average Volume: 1.26 million shs
• Market Capitalization: $13.40 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

GELS Stock Analysis - Frequently Asked Questions

How have GELS shares performed this year?

Gelteq's stock was trading at $2.32 on January 1st, 2025. Since then, GELS shares have decreased by 38.8% and is now trading at $1.42.

When did Gelteq IPO?

Gelteq (GELS) raised $5 million in an initial public offering (IPO) on Tuesday, October 29th 2024. The company issued 1,300,000 shares at a price of $4.00 per share. The Benchmark Company acted as the underwriter for the IPO.

Who are Gelteq's major shareholders?

Gelteq's top institutional shareholders include Wedbush Securities Inc. (0.21%).

How do I buy shares of Gelteq?

Shares of GELS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 8/14/2025
• Fiscal Year End: 6/30/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:GELS
• Previous Symbol: NASDAQ:GELS
• CIK: 1920092
• Web: www.gelteq.com
• Phone: 61-3-9087-3990
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.79
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $100 thousand
• Price / Sales: 134.05
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.30 per share
• Price / Book: 1.09

Miscellaneous

• Outstanding Shares: 9,440,000
• Free Float: N/A
• Market Cap: $13.40 million
• Optionable: N/A
• Beta: N/A